Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-27 @ 12:08 PM
Study NCT ID:
NCT00035360
Status:
COMPLETED
Last Update Posted:
2017-03-10
First Post:
2002-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III PEG-Intron in HIV-infected Patients (Study P00738)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-03
Start Date Type:
None
Primary Completion Date:
2003-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-10
Completion Date Type:
ACTUAL
First Submit Date:
2002-05-02
First Submit QC Date:
None
Study First Post Date:
2002-05-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-07
Last Update Post Date:
2017-03-10
Last Update Post Date Type:
ACTUAL